Phenotypic analysis of peripheral T cell lymphoma among the Japanese
Authors:
- 1 July 1993
- journal article
- Published by Wiley in Acta Pathologica Japonica
- Vol. 43 (7-8) , 396-412
Abstract
From 1980 to 1990, 174 peripheral T cell lymphomas were studied morphologically and immunophenotypically with a panel of monoclonal antibodies which were reactive with T cell differentiation antigens in cryostat sections and/or cell suspensions. Histologically, 57% of the lymphomas were categorized into low‐grade tumors according to the updated Kiel classification, while 41% were high‐grade tumors. By immunologic studies, 50% of the lymphomas were of helper/inducer (CD4) phenotype, 6% were of cytotoxic/suppressor (CD8) phenotype, 3% expressed both CD4 and CD8, 3% lacked both CD4 and CD8, and 36% were phenotypically undetermined because of an admixture of a fairly even number of CD4 and CD8‐positive cells. The phenotypically undetermined cases were more frequently noted in the low‐grade groups than in the high‐grade group, and the latter often showed a loss of pan‐T antigens, although there was no definite correlation between the histologic category and the immunophenotype. CD25, which is strongly manifested in anti‐HTLV‐1 antibody‐positive cases, was negative or only weakly expressed in anti‐HTLV‐1 antibody‐negative cases. Anaplastic large cell lymphomas (LC‐Ana) strongly expressed CD30, which was also detectable in only large blast‐like cells in the low‐grade tumors. Seventy‐one per cent of the lymphomas expressed la antigens. In this series, the clinical data were available on 154 patients. For individual markers, the expression of CD30 and HLA‐DR were associated with a longer actuarial survival (P< 0.01 and P < 0.05 by the generalized Wilcoxon test). The absence of CD25 or the presence of CD3 on tumor cells correlated with a relatively favorable prognosis, but not significantly. The detection of CD4 and CD8 had relatively little prognostic value. In the cases excluding LC‐Ana, a significant difference was also recognized between the groups with and without CD25, CD30 and HLA‐DR (P < 0.05 by the generalized Wilcoxon test). These results suggest that the immunophenotypic analysis of peripheral T cell lymphoma provided its use as an adjunct to a histopathologic diagnosis and was related to prognostic prediction.Keywords
This publication has 47 references indexed in Scilit:
- HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma.Journal of Clinical Investigation, 1988
- UPDATED KIEL CLASSIFICATION FOR LYMPHOMASThe Lancet, 1988
- Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.Journal of Clinical Pathology, 1987
- Peripheral T-Cell Lymphomas: Histologic, Immunohistologic, and Clinical CharacterizationMayo Clinic Proceedings, 1986
- Lymphoma immunotyping by paraffin immunoperoxidase and cell suspension methods – A comparative studyPathology, 1986
- The pathologic spectrum of adult T-cell leukemia/lymphoma in the United StatesAmerican Journal of Surgical Pathology, 1984
- Phenotypic Characterization of Cutaneous T-Cell LymphomaNew England Journal of Medicine, 1981
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Large‐Cell T‐Lymphoma with Hypersegmented NucleiScandinavian Journal of Haematology, 1981
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976